News & Events

News

TSO3 Discloses Fourth Quarter and Full Year 2010 Fiscal Results and Updates on Subsequent Activities

Quebec City, March 16, 2011 – TSO3 Inc. (“TSO3”) an innovator in sterilization technology for medical devices in healthcare settings using ozone, today reported sales for the fiscal year ending December 31, 2010 totalling $939,285 representing the sale of four new generation sterilizers (3M™ Optreoz™ 125-Z) to 3M™ for training purposes. This compares to $1.3 million the previous year for the sale of the first generation sterilizers sold directly to end-users (TSO3 STERIZONE® 125L).

Read more

TSO3: conference call and webcast for the 2010 annual financial results

Quebec City, March 7, 2011 – TSO3 Inc. (“TSO3”) (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings using ozone, today announced that it will report the Company’s annual financial results ending December 31, 2010, on Wednesday, March 16, 2011. TSO3 will host a conference call at 10:30 A.M. (EDST) the same day.

Read more

Events

Sorry, no posts matched your criteria.